Five things for pharma marketers to know: Friday, March 2, 2018

Share this content:

Uber debuts Uber Health for rides to doctor appointments. The ride-hailing company launched the b-to-b health business on Thursday. The service will bill providers' offices that set up the rides, rather than the patient. The service could help low-income patients make it to the doctor. (Associated Press)


President Donald Trump called for a federal lawsuit against opioid manufacturers. The president called on Attorney General Jeff Sessions to pursue legal action against drugmakers. Many cities and states have sued opioid companies for deceptive marketing and failing to take action to curb the epidemic. (Reuters)


Mylan has partnered with Relevance for Botox biosimilar. The embattled maker of EpiPen is hoping to rev its U.S. sales back up with the copycat of Allergan's drug. (FiercePharma)

Kentucky is weighing a tax on prescription opioids
. In yet another effort to curb the opioid epidemic, Kentucky lawmakers have proposed a 25-cent levy on drug distributors for every dose sent to the state, which could decrease the number of pills coming to Kentucky. (STAT)


Biogen and AbbVie have pulled marketing for MS drug Zinbryta after European regulators flagged a lethal safety warning. The drug is being pulled in both E.U. and U.S. markets after cases of brain infections inflammatory encephalitis and meningoencephalitis appeared. (Endpoints News)
Share this content:
Scroll down to see the next article